Is a complete IPSC research report available?

No complete published report is available for Century Therapeutics, Inc. (IPSC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · USD

$2.11

-0.06 (-2.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IPSC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	380.5M
Net income (ttm)	-107.8M
EPS (ttm)	-$0.95
Shares out	180.4M
Volume	678,432
Beta	1.56
Price target	$4.75	+125.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -107.8M
EPS (ttm): -$0.95
Market cap: 380.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IPSC indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001850119
Company name	Century Therapeutics, Inc.
Country	United States
Country code	US
Cusip	15673T100
Employees	78
Employees Change	-72%
Employees Change Percent	-48
Enterprise value	$296.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-06-18
Isin	US15673T1007
Last refreshed	2026-07-25
Market cap	$380.5M
Market cap category	Small-Cap
Price	$2.11
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	IPSC
Website	https://www.centurytx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.14%
FCF yield	-24.92%
P/B ratio	1.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-86.2M
Net Income	$-107.8M
Net Income Growth Years	2%
Profit Per Employee	$-1.4M
ROA	-22.28
Roa5y	-16.79
ROCE	-36.78
ROE	-42.67
Roe5y	-42.69
ROIC	-23.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	231.51%
Cagr3y	-12.22%
Cagr5y	-40.89%
EPS Growth Years	2
Revenue Growth	1,556.76x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$326.6M
Cash	$134.8M
Current Assets	$139M
Current Liabilities	$13.6M
Debt	$48M
Debt Equity	$0.18
Equity	$264.7M
Liabilities	$61.8M
Long Term Assets	$187.5M
Long Term Liabilities	$48.2M
Net Cash	$86.8M
Net Cash By Market Cap	$22.65
Net Cash Growth	-22.83%
Net Debt Equity	$-0.33
Tangible Book Value	$230.5M
Tangible Book Value Per Share	$1.28
WACC	11.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.25
Net Working Capital	$-5.2M
Quick ratio	10.04
Working Capital	$125.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-34.1%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	231.24%
200-day SMA	1.73
3Y total return	-32.37%
50-day SMA	2.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-92.78%
All Time High	32.9
All Time High Change	-93.59%
All Time High Date	2021-08-17
All Time Low	0.34
All Time Low Change	517.32%
All Time Low Date	2025-04-09
ATR	0.15
Beta	1.56
Beta1y	2.44
Beta2y	2.01
Ch YTD	112.1
High	2.18
High52	3.04
High52 Date	2026-03-10
High52ch	-30.59%
Low	2.08
Low52	0.44
Low52 Date	2025-11-17
Low52ch	385.06%
Ma50ch	-6.84%
Price vs 200-day SMA	22.25%
RSI	41.54
RSI Monthly	44.84
RSI Weekly	52.36
Sharpe ratio	1.65x
Sortino ratio	3.22
Total Return	-34.1%
Tr YTD	112.1
Tr1m	-12.45%
Tr1w	-6.22%
Tr3m	-6.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$5.8
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.12
Operating Income	$-114.5M
Price target	$4.75
Price Target Change	$125
Price Target Change Top	$175

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100,129,528%
Float Percent	55.52%
Shares Insiders	1.9%
Shares Institutions	46.63%
Shares Out	180,354,809
Shares Qo Q	121.65%
Shares Yo Y	34.1%
Short Float	23.43%
Short Ratio	12
Short Shares	13.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-101.3M
Average Volume	2,105,820.15x
Bv Per Share	1.47
CAPEX	$-957,000
Ch1m	-12.45
Ch1w	-6.22
Ch1y	231.2
Ch3m	-6.64
Ch3y	-32.37
Ch5y	-92.78
Ch6m	-12.81
Change	-2.76%
Change From Open	-3.21
Close	2.17
Days Gap	0.46
Depreciation Amortization	12,884,000
Dollar Volume	1,431,491.5
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-115.1M
EBITDA	$-102.2M
EPS	$-0.95
F Score	1
FCF	$-95.5M
FCF EV Yield	-32.22x
FCF Per Share	$-0.53
Financing CF	126,676,000
Fiscal Year End	December
Founded	2,019
Income Tax	$-68,000
Investing CF	-33,044,000
Ipr	-89.38
Iprfo	-89.11
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	2.12
Ma150ch	-0.33%
Ma20	2.28
Ma20ch	-7.42%
Net CF	-883,000
Next Earnings Date	2026-08-13
Open	2.18
Optionable	Yes
Position In Range	30
Post Close	2.11
Postmarket Change Percent	-1.35
Postmarket Price	$2.08
Ppne	68,578,000
Price Date	2026-07-24
Ptbv Ratio	1.66
Relative Volume	0.32x
Share Based Comp	5,859,000
Tr6m	-12.81%
Us State	Pennsylvania
Volume	678,432
Z Score	-3.09

Century Therapeutics, Inc. (IPSC)

Coverage state: Market snapshot only — no published research

Generate the first IPSC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IPSC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IPSC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IPSC

Frequently asked questions